Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency
NCT02558829Phase 3Completed
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Dec 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of macimorelin in growth hormone deficiency (GHD), sponsored by COSCIENS Biopharma Inc.. Started Dec 2015; status: completed.
02
Drugs
macimorelin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT02558829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02558829.